References
- Hiller S A, Zhuk R A, Lidak M J, et al. Patent specification 1168391. Br Patent No. 1:391–395, 1968
- Toide H, Akiyoshi H, Minato Y, et al. Comparative studies on the metabolism of 2-(tetrahydrofuryl)-5-fluorouracil. Gann 1977; 68: 553–560
- Fujii S, Kitano S, Ikenaka K, et al. Studies on coadministration of uracil or cytosine on antitumor activity of FT-207 or 5-FU derivatives. Jpn J Cancer Chemother 1979; 6: 377–384
- Fujii S, Ikenaka K, Fukushima M, et al. Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Gann 1978; 69: 763–772
- Taguchi T, Nakano Y, Jikuya K, et al. Effect of uracil on the antitumor activity of Futraful. Jpn J Cancer Chemother 1978; 5: 1161–1165
- Taguchi T, Nakano Y, Fujii S, et al. Determination of 5-fluorouracil levels in tumors, blood, and other tissues. Jpn J Cancer Chemother 1978; 5: 1167–1172
- Unemi N, Takeda S, Tajima K, et al. studies on combination therapy with 1-(tetrahydro-2 furanyl)-5-fluorouracil plus uracil. I. Effect of coadministration of uracil on the antitumor activity of l-(tetrahydro-2-furanyl)-5-fluorouracil and the level of 5-fluorouracil in AH 130 bearing rats. Chemotherapy 1981; 29: 164–175
- Unemi N, Takeda S. Studies on combination therapy with 1-(tetrahydro-2-furanyl)-5-fluorouracil plus uracil. II. Effect of uracil on in vivo metabolism of 1 -(tetrahydro-2-furanyl)-5-fluoro-uracil and 5-fluorouracil. Chemotherapy 1981; 29: 176–184
- Nakamura H, Wang Y, Miyauchi S, et al. Studies on the mechanism of antitumor activity of 5-FU and its derivatives–Relationship between the inhibition of tumor growth and the inhibition of thymidylate synthase in vivo. Jpn J Cancer Chemother 1984; 11: 1049–1055
- Miwa M, Eda H, Fukuda H, et al. Comparative studies on the antitumor activity of fluorinated pyrimidines, 5′-DFUR, Tega-fur, UFT and FUra, with various murine tumors. Jpn J Cancer Chemother 1988; 15: 1755–1763
- Nakajima O, Ihara K, Isoda T, et al. Phase I and II studies on a mixture of l-(2-tetrahydrofuryl)-5-fluorouracil and uracil(UFT). Jpn J Cancer Chemother 1980; 7: 1558–1568
- Higashigawa M, Ido M, Ohkubo T, et al. Increased sensitivity to 1-β-D-arabinofuranosylcytosine in P388 murine leukemic cells resistant to etoposide. Leukemia Res 1989; 13: 39–42
- Cadman E, Eiferman F. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside. J Clin Invest 1979; 64: 788–797
- Yoshioka A, Tanaka S, Hiraoka O, et al. Deoxyribonucleoside triphosphate imbalance. J Biol Chem 1987; 262: 8235–8241